HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Fiona Blackhall Selected Research
Fiona Blackhall Research Topics
Disease
51
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2023 - 06/2005
40
Neoplasms (Cancer)
01/2023 - 04/2007
31
Lung Neoplasms (Lung Cancer)
10/2023 - 08/2004
28
Small Cell Lung Carcinoma (Small Cell Lung Cancer)
02/2024 - 01/2010
12
Disease Progression
01/2023 - 06/2012
8
Neoplasm Metastasis (Metastasis)
10/2023 - 11/2011
6
Fatigue
01/2023 - 06/2013
6
Circulating Neoplastic Cells
01/2020 - 10/2013
4
Dyspnea (Shortness of Breath)
10/2022 - 06/2013
3
Nausea
10/2022 - 12/2014
3
Cough
01/2021 - 11/2014
3
Hypoxia (Hypoxemia)
01/2018 - 03/2011
3
Epilepsy (Aura)
10/2017 - 04/2017
3
Thrombocytopenia (Thrombopenia)
09/2017 - 10/2011
3
Neutropenia
01/2017 - 08/2015
2
Melanoma (Melanoma, Malignant)
01/2023 - 08/2016
2
Pain (Aches)
01/2023 - 11/2014
2
Hemoptysis
01/2023 - 08/2014
2
Edema (Dropsy)
01/2021 - 12/2014
2
Vomiting
01/2021 - 12/2014
2
Febrile Neutropenia
09/2017 - 10/2011
2
Colorectal Neoplasms (Colorectal Cancer)
01/2016 - 03/2011
2
Diarrhea
12/2014 - 11/2014
2
Vision Disorders (Hemeralopia)
12/2014 - 06/2013
2
Adenocarcinoma
08/2012 - 06/2010
1
Adenocarcinoma of Lung
10/2023
1
Neuroendocrine Carcinoma
01/2023
1
Kidney Neoplasms (Kidney Cancer)
01/2023
1
Ovarian Neoplasms (Ovarian Cancer)
10/2022
1
Hyponatremia
10/2021
1
Thoracic Diseases
01/2019
1
Myositis (Idiopathic Inflammatory Myopathies)
01/2018
Drug/Important Bio-Agent (IBA)
15
Biomarkers (Surrogate Marker)
IBA
01/2023 - 08/2008
10
Platinum
IBA
10/2022 - 07/2005
8
ErbB Receptors (EGF Receptor)
IBA
07/2018 - 01/2005
8
Carboplatin (JM8)
FDA Link
Generic
09/2017 - 12/2007
7
Crizotinib
IBA
01/2018 - 02/2013
6
Tyrosine Kinase Inhibitors
IBA
09/2021 - 01/2005
6
Paclitaxel (Taxol)
FDA Link
Generic
08/2014 - 12/2007
5
Docetaxel (Taxotere)
FDA Link
01/2017 - 12/2007
4
Proteins (Proteins, Gene)
FDA Link
10/2023 - 03/2011
4
osimertinib
IBA
07/2018 - 04/2017
4
Anaplastic Lymphoma Kinase
IBA
01/2018 - 02/2013
4
Erlotinib Hydrochloride (CP 358,774)
FDA Link
09/2017 - 06/2005
4
Gefitinib (Iressa)
FDA Link
02/2013 - 01/2005
3
Ligands
IBA
11/2023 - 01/2021
3
DNA (Deoxyribonucleic Acid)
IBA
10/2022 - 01/2017
3
Gemcitabine
FDA Link
09/2017 - 12/2007
3
Pemetrexed (MTA)
FDA Link
09/2017 - 07/2014
3
Cisplatin (Platino)
FDA Link
Generic
09/2017 - 04/2011
3
AZD 6244
IBA
09/2017 - 11/2016
2
Cadherins (E-Cadherin)
IBA
10/2023 - 03/2011
2
pembrolizumab
IBA
01/2023 - 01/2022
2
olaparib
IBA
10/2022 - 10/2018
2
Cell-Free Nucleic Acids
IBA
10/2022 - 01/2020
2
Poly(ADP-ribose) Polymerase Inhibitors
IBA
10/2022 - 10/2018
2
Etoposide (VP 16)
FDA Link
Generic
11/2021 - 04/2011
2
Granulocyte Colony-Stimulating Factor (G-CSF)
IBA
01/2021 - 10/2011
2
Antitussive Agents (Antitussives)
FDA Link
01/2021 - 04/2017
2
Immune Checkpoint Inhibitors
IBA
01/2020 - 07/2018
2
Epitopes
IBA
01/2020 - 01/2016
2
MicroRNAs (MicroRNA)
IBA
02/2016 - 12/2013
2
ABT-737
IBA
01/2016 - 03/2011
2
motesanib diphosphate
IBA
08/2014 - 08/2012
2
Vascular Endothelial Growth Factor Receptors (VEGF Receptors)
IBA
08/2014 - 08/2012
2
human TNFSF10 protein
IBA
11/2011 - 03/2010
2
Bevacizumab (Avastin)
FDA Link
11/2011 - 03/2010
1
Transcription Factors (Transcription Factor)
IBA
02/2024
1
Guanine Nucleotide Exchange Factors (Guanine Nucleotide Exchange Factor)
IBA
10/2023
1
Protocadherins
IBA
10/2023
1
Chimeric Antigen Receptors
IBA
01/2023
1
Immunoconjugates (Immunoconjugate)
IBA
01/2023
1
AMG 757
IBA
01/2023
1
Smoke
IBA
12/2022
1
Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)
IBA
10/2022
1
Soluble Guanylyl Cyclase
IBA
11/2021
1
Monomeric GTP-Binding Proteins
IBA
11/2021
1
Tolvaptan
FDA Link
10/2021
1
erythromycin propionate-N-acetylcysteinate
IBA
04/2021
1
Topotecan (Hycamtin)
FDA Link
Generic
01/2021
1
Substance P
IBA
01/2021
1
Aprepitant (Emend)
FDA Link
01/2021
1
Neurokinin-1 Receptors (Neurokinin 1 Receptor)
IBA
01/2021
1
Colony-Stimulating Factors (Colony Stimulating Factor)
IBA
01/2021
1
Anti-Bacterial Agents (Antibiotics)
IBA
01/2020
1
Phosphotransferases (Kinase)
IBA
10/2018
1
adavosertib
IBA
10/2018
1
Circulating Tumor DNA
IBA
07/2018
1
methylamphotericin B (AME)
IBA
07/2018
1
Ligases (Synthetase)
IBA
01/2018
1
Hepatocyte Growth Factor (Growth Factor, Hepatocyte)
IBA
01/2018
1
transcriptional intermediary factor 1
IBA
01/2018
1
nuclear matrix protein 2
IBA
01/2018
Therapy/Procedure
36
Drug Therapy (Chemotherapy)
06/2023 - 01/2005
32
Therapeutics
01/2023 - 06/2005
19
Radiotherapy
06/2023 - 01/2005
6
Immunotherapy
11/2023 - 08/2016
6
Chemoradiotherapy
01/2019 - 07/2005
2
Aftercare (After-Treatment)
10/2017 - 12/2013
1
Cranial Irradiation
01/2019